Skip to main content

UBS Group AG

Position in NXTC — NextCure, Inc.

CIK 1610520 ZURICH, V8

Position in NXTC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$949
-$2,660 QoQ
Shares Held
594
+75.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 30 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 47% Shared 0% None 53%

Common Shares in NXTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. NXTC ranks #515 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NXTC

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $949 594
2026-03-31 $3,609 338
2025-12-31 $4,796 338
2025-09-30 $3,520 601
2025-06-30 $5,656 12,299
2025-03-31 $4,096 8,537
2024-12-31 $3,239 4,202
2024-09-30 $7,487 5,466
2024-06-30 $15,784 9,928
2024-03-31 $24,112 10,813
2023-12-31 $7,143 6,267
2023-09-30 $15,087 11,697
2023-06-30 $28,193 15,664
2023-03-31 $18,849 12,737
2022-12-31 $14,985 10,628
2022-09-30 $27,436 9,977
2022-06-30 $43,836 9,327
2022-03-31 $44,517 9,160
2021-12-31 $16,931 2,822
2021-09-30 $276 41
2021-06-30 $144 18
2021-03-31 $21,231 2,121
2020-12-31 $84,180 7,723
2020-09-30 $448 51
2020-03-31 $339,301 9,153